Long-acting insulin analogs and the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes: A prospective study of 10,682 patients from 271 institutions

Diabetes Care

Volumn 33, Issue 5, 2010, Pages 1031-1033

  Karges, Beate ^a   Kapellen, Thomas ^b   Neu, Andreas ^c   Hofer, Sabine E ^d   Rohrer, Tilman ^e   Rosenbauer, Joachim ^f   Wolf, Johannes ^g   Holl, Reinhard W ^h  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e SAARLAND UNIVERSITY   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g Children's Hospital   (Germany)

^h UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLARGINE; INSULIN; LONG ACTING INSULIN;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE DURATION; FEMALE; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT DURATION; CLINICAL TRIAL; INCIDENCE; MULTICENTER STUDY; RISK FACTOR;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; INSULIN, LONG-ACTING; INSULIN, NPH; MALE; RISK FACTORS;

EID: 77952905246     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-2249     Document Type: Article

References (11)

1. Wagner A, Risse A, Brill HL, Wienhausen-Wilke V, Rottmann M, Sondern K, Angelkort B. Therapy of severe diabetic ketoacidosis: zero-mortality under very-low-dose insulin application. Diabetes Care 1999;22:674-677
2. DeFronzo R, Matsuda M, Barret E. Diabetic ketoacidosis: a combined metabolic-nephrologic approach to therapy. Diabetes Rev 1994;2:209-238 (Pubitemid 24184311)
3. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet 1997;350:1505-1510
4. Burdick J, Chase HP, Slover RH, Knievel K, Scrimgeour L, Maniatis A, Klingensmith GJ. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics 2004;113:221-224
5. Wagner VM, Rosenbauer J, Grabert M, Holl RW, the German Initiative on Quality Control in Pediatric Diabetology. Severe hypoglycemia, metabolic control, and diabetes management in young children with type 1 diabetes using insulin analogs: a follow-up report of a large multicenter database. Eur J Pediatr 2008;167:241-242
6. Porcellati F, Rossetti P, Busciantella NR, Marzotti S, Lucidi P, Luzio S, Owens DR, Bolli GB, Fanelli CG. Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes. Diabetes Care 2007;30:2447-2452
7. Bangstad HJ, Danne T, Deeb LC, Jarosz-Chobot P, Urakami T, Hanas R. Insulin treatment. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Pediatr Diabetes 2007;8:88-102
8. Robertson KJ, Schoenle E, Gucev Z, Mordhorst L, Gall MA, Ludvigsson J. Insulin detemir compared with NPH insulin in children and adolescents with type 1 diabetes. Diabet Med 2007;24:27-34 (Pubitemid 46103068)
9. Schwab KO, Doerfer J, Hecker W, Grulich-Henn J, Wiemann D, Kordonouri O, Beyer P, Holl RW, the DPV Initiative of the German Working Group for Pediatric Diabetology. Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care 2006;29:218-225
10. Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J, Lee WRW, Rosenbloom A, Sperling MA, Hanas R. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Diabetic ketoacidosis. Pediatr Diabetes 2007;8:28-43
11. Rewers A, Chase HP, Mackenzie T, Walravens P, Roback M, Rewers M, Hamman RF, Klingensmith G. Predictors of acute complications in children with type 1 diabetes. JAMA 2002;287:2511-2518 (Pubitemid 34517196)